Germany-headquartered specialty chemicals supplier Cognis has opened a wholly-owned affiliate in Selangor, Malaysia, called Cognis Malaysia Sdn Bhd. The aim is to accelerate the group's growth in the region by improving the level of service it offers to customers there. The decision to open an affiliate in Malaysia reflects the country's strategic importance to Cognis, the company noted.
The Asia-Pacific region is now Cognis' third biggest market after Europe and North America, so it was a logical step for the company to devote more resources to its operations in this region. The founding of a dedicated Malaysian affiliate is in keeping with the company's focus on high-growth markets driven by the wellness and sustainability trends. It represents a significant milestone in Cognis' activities in the Malaysian market, which has experienced rapid growth in recent years. Cognis Malaysia will employ technical and commercial managers to work on behalf of all three of the company's strategic business units - Care Chemicals, Nutrition & Health and Functional Products.
Jimmy Lau, legal representative of Cognis Malaysia, comments: 'We believe that Malaysia and the whole Asia-Pacific region has significant growth potential that is fully in line with Cognis' strategy. By opening an affiliate in Malaysia, we want to gain a deeper understanding of the local market and be closer to our customers. We aim to double Cognis' sales in Malaysia over the next five years by helping our customers to gain the competitive edge they need to succeed.'
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze